Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: July 2012
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Canine EIC Genetics, LLC v. DNA Diagnostics Center, Inc.0:12-cv-01668; filed July 11, 2012 in the District Court of Minnesota Canine EIC Genetics, LLC v. Animal Genetics, Inc.0:12-cv-01667; filed July 11, 2012 in the District Court…
-
July 17-19, 2012 – Product and Pipeline Enhancement for Generics*** (marcus evans) – Washington, DC July 18, 2012 – EPO Biotechnology Case Law Update (D Young & Co.) – 4:00 am, 7:00 am, 12:00 pm (all times EDT) July 19, 2012 – Update on Reverse Payment Settlements in Hatch-Waxman Litigation (Intellectual Property Owners Association) –…
-
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on September 20-21, 2012 in Boston, MA. ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices;• Comprehend the structure of the FDA and the roles of the three…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar providing an "Update on Reverse Payment Settlements in Hatch-Waxman Litigation" on July 19, 2012 beginning at 2:00 pm (ET). A panel consisting of John M. Griem, Jr. of Loeb & Loeb; Patricia Clarke Lukens, Vice President, Law at Janssen Pharmaceuticals, Inc.; and Michael Perry…
-
By Kevin E. Noonan — Darwin, Mendel, Watson and Crick — a good case can be made that these four men make up the basis of modern biology as a science (as opposed to natural history). As such, their contributions to human understanding, of ourselves and the natural world around us, will be remembered for…
-
By Kevin E. Noonan — Dr. Christopher Holman, Associate Professor of Law at the University of Missouri-Kansas City, filed an amicus curiae brief in AMP v. USPTO (the Myriad case) that addresses some of the factual and scientific inaccuracies that have been rampant in commentary and advocacy of this case at both the District Court…
-
Valeant International (Barbados) SRL v. Watson Pharmaceuticals, Inc. By Andrew Williams — On Monday, the Southern District of Florida denied Valeant International (Barbados) SRL's motion for a permanent injunction to prevent Watson Pharmaceuticals, Inc. from commercially manufacturing or selling its generic version of Aplenzin® (see Order Denying Motion for Injunctive Relief). Valeant had been successful…
-
By Donald Zuhn — In its amicus brief filed in Association for Molecular Pathology v. U.S. Patent and Trademark Office ("Myriad"), the United States focuses solely on applicability of the Supreme Court's decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. on the patent eligibility of isolated genomic DNA. The U.S. brief takes no position…
-
By Donald Zuhn — With oral argument in Association for Molecular Pathology v. U.S. Patent and Trademark Office ("Myriad") less than two weeks away, Patent Docs continues its examination of some of the twenty-three amicus briefs that have been filed in this case. Today, we look at the amicus brief filed by the Intellectual Property…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Pfizer Inc. et al. v. Roxane Laboratories, Inc. et al.2:12-cv-00593; filed July 3, 2012 in the Southern District of Ohio • Plaintiffs: Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; P.F. Prism C.V.• Defendants: Roxane Laboratories,…
Patent Docs 